Aquestive Therapeutics
AQST
AQST
178 hedge funds and large institutions have $298M invested in Aquestive Therapeutics in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 55 increasing their positions, 48 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.33% less ownership
Funds ownership: 59.13% → 58.8% (-0.33%)
36% less capital invested
Capital invested by funds: $466M → $298M (-$168M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
178
Holding in Top 10
2
Calls
$9.58M
Puts
$2.14M
Top Buyers
| 1 | +$7.83M | |
| 2 | +$4.86M | |
| 3 | +$4.77M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$3.77M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.68M |
Top Sellers
| 1 | -$17M | |
| 2 | -$6.43M | |
| 3 | -$6.13M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$5.23M |
| 5 |
PA
Perceptive Advisors
New York
|
-$4.83M |
